by | Oct 5, 2022 | Publications
Rev Inst Med Trop Sao Paulo. 2022 Sep 30;64:e64. doi: 10.1590/S1678-9946202264064. eCollection 2022. ABSTRACT Interferon-gamma (IFN-γ) plays a crucial role in viral infections by preventing viral replication and in the promotion of innate and adaptive immune...
by | Oct 4, 2022 | Publications
Anticancer Res. 2022 Oct;42(10):4743-4752. doi: 10.21873/anticanres.15979. Epub 2022 Oct 3. ABSTRACT BACKGROUND/AIM: Acute myeloid leukemia (AML) with high expression of the oncogenic transcription factor ecotropic viral integration site-1 (EVI1) (EVI1high AML) is...
by | Oct 3, 2022 | Publications
Front Immunol. 2022 Sep 16;13:959962. doi: 10.3389/fimmu.2022.959962. eCollection 2022. ABSTRACT HTLV-1 is an oncovirus causing ATL and other inflammatory diseases such as HAM/TSP and HU in about 5% of infected individuals. It is also known that HTLV-1-infected cells...
by | Oct 3, 2022 | Publications
Front Immunol. 2022 Sep 15;13:984274. doi: 10.3389/fimmu.2022.984274. eCollection 2022. ABSTRACT Human T lymphotropic virus 1 (HTLV-1) is a human retrovirus identified as the causative agent in adult T-cell leukemia/lymphoma (ATL) and chronic-progressive...
by | Oct 2, 2022 | Publications
Cancer Immunol Immunother. 2022 Oct 1. doi: 10.1007/s00262-022-03301-6. Online ahead of print. ABSTRACT Adult T cell leukemia/lymphoma (ATLL) is a CD4-positive peripheral T cell lymphoma caused by human T cell lymphotropic virus type 1 (HTLV-1). Although ATLL is quite...
by | Sep 30, 2022 | Publications
Front Immunol. 2022 Sep 13;13:921606. doi: 10.3389/fimmu.2022.921606. eCollection 2022. ABSTRACT Human T-cell leukemia virus type-1 (HTLV-1) establishes a long-term persistent infection in humans and causes malignant T-cell leukemia, adult T-cell leukemia (ATL)....